These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 18179388)
1. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. Lim JK; Louie CY; Glaser C; Jean C; Johnson B; Johnson H; McDermott DH; Murphy PM J Infect Dis; 2008 Jan; 197(2):262-5. PubMed ID: 18179388 [TBL] [Abstract][Full Text] [Related]
2. CCR5 deficiency increases risk of symptomatic West Nile virus infection. Glass WG; McDermott DH; Lim JK; Lekhong S; Yu SF; Frank WA; Pape J; Cheshier RC; Murphy PM J Exp Med; 2006 Jan; 203(1):35-40. PubMed ID: 16418398 [TBL] [Abstract][Full Text] [Related]
3. A genetic basis for human susceptibility to West Nile virus. Diamond MS; Klein RS Trends Microbiol; 2006 Jul; 14(7):287-9. PubMed ID: 16750369 [TBL] [Abstract][Full Text] [Related]
4. A moving target: the multiple roles of CCR5 in infectious diseases. Klein RS J Infect Dis; 2008 Jan; 197(2):183-6. PubMed ID: 18179384 [No Abstract] [Full Text] [Related]
5. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. Lim JK; McDermott DH; Lisco A; Foster GA; Krysztof D; Follmann D; Stramer SL; Murphy PM J Infect Dis; 2010 Jan; 201(2):178-85. PubMed ID: 20025530 [TBL] [Abstract][Full Text] [Related]
6. The emergence of west nile virus during a large outbreak in Illinois in 2002. Huhn GD; Austin C; Langkop C; Kelly K; Lucht R; Lampman R; Novak R; Haramis L; Boker R; Smith S; Chudoba M; Gerber S; Conover C; Dworkin MS Am J Trop Med Hyg; 2005 Jun; 72(6):768-76. PubMed ID: 15964962 [TBL] [Abstract][Full Text] [Related]
7. CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection. Lim JK; Glass WG; McDermott DH; Murphy PM Trends Immunol; 2006 Jul; 27(7):308-12. PubMed ID: 16753343 [TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. Glass WG; Lim JK; Cholera R; Pletnev AG; Gao JL; Murphy PM J Exp Med; 2005 Oct; 202(8):1087-98. PubMed ID: 16230476 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of West Nile virus infection in solid organ transplant recipients. Freifeld AG; Meza J; Schweitzer B; Shafer L; Kalil AC; Sambol AR Transpl Infect Dis; 2010 Apr; 12(2):120-6. PubMed ID: 19874565 [TBL] [Abstract][Full Text] [Related]
10. Non-neuroinvasive West Nile virus infections during the outbreak in Greece. Anastasiadou A; Economopoulou A; Kakoulidis I; Zilidou R; Butel D; Zorpidou D; Ferentinos G; Markou P; Kougas E; Papa A Clin Microbiol Infect; 2011 Nov; 17(11):1681-3. PubMed ID: 21880099 [TBL] [Abstract][Full Text] [Related]
11. Excretion of West Nile virus in urine during acute infection. Barzon L; Pacenti M; Franchin E; Pagni S; Martello T; Cattai M; Cusinato R; Palù G J Infect Dis; 2013 Oct; 208(7):1086-92. PubMed ID: 23821721 [TBL] [Abstract][Full Text] [Related]
12. Seasonality and survival associated with three outbreak seasons of West Nile virus disease in Oklahoma--2003, 2007, and 2012. Johnson MG; Adams J; McDonald-Hamm C; Wendelboe A; Bradley KK J Med Virol; 2015 Oct; 87(10):1633-40. PubMed ID: 25946680 [TBL] [Abstract][Full Text] [Related]
13. Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010. Gibney KB; Colborn J; Baty S; Bunko Patterson AM; Sylvester T; Briggs G; Stewart T; Levy C; Komatsu K; MacMillan K; Delorey MJ; Mutebi JP; Fischer M; Staples JE Am J Trop Med Hyg; 2012 May; 86(5):895-901. PubMed ID: 22556093 [TBL] [Abstract][Full Text] [Related]
14. West Nile virus and kidney disease. Barzon L; Pacenti M; Palù G Expert Rev Anti Infect Ther; 2013 May; 11(5):479-87. PubMed ID: 23627854 [TBL] [Abstract][Full Text] [Related]
15. West Nile virus activity--United States, July 21-27, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(29):661-2. PubMed ID: 15282450 [TBL] [Abstract][Full Text] [Related]
16. Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Barzon L; Pacenti M; Franchin E; Martello T; Lavezzo E; Squarzon L; Toppo S; Fiorin F; Marchiori G; Scotton GP; Russo F; Cattai M; Cusinato R; Palù G Euro Surveill; 2012 Sep; 17(36):20260. PubMed ID: 22971328 [TBL] [Abstract][Full Text] [Related]
17. West Nile virus activity--United States, August 11-17, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(32):742-3. PubMed ID: 15318160 [TBL] [Abstract][Full Text] [Related]
18. West Nile virus activity--United States, August 21-28, 2002, and Illinois, January 1-August 27, 2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Aug; 51(34):764-6. PubMed ID: 12219748 [TBL] [Abstract][Full Text] [Related]
19. West Nile virus activity--United States, August 18-24, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(33):770-1. PubMed ID: 15329654 [TBL] [Abstract][Full Text] [Related]
20. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]